30 Day Trial

ChoiceSpine Launches Biologics Portfolio

Share:

ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware. STRATOFUSE™ comprises demineralized bone allograft putties and sponges, synthetic bone graft substitute putties and strips, structural allograft and allograft bone extenders. STRATOGEN™ includes a full amnion offering.

The addition of the biologics line follows ChoiceSpine’s 1Q17 acquisition of Exactech’s spine products, which encompass cervical, thoracolumbar and interbody implants and minimally invasive instrument systems. 

Sources: ChoiceSpine; ORTHOWORLD Inc.